The potential of the anti VEGF drugs cannot be used under real life conditions in Germany: Results from a 4 year follow up of 77 patients

Wolfgang F Schrader, A. Bernhard, C. Dietz, K. Sommer & E. Panidou
Background: Visual acuity (VA) can be preserved by 4-weekly intravitreal injections (IVI) of ranibizumab over >2 years (yrs). The CATT-trial showed that a PRN (pro re nata) treatment (TX) based on a monthly follow up (FU) is not inferior to a monthly IVI TX. In Germany, most insurance companies[for full text, please go to the a.m. URL]